The Use of Live Attenuated Influenza Vaccine (LAIV) in Healthcare Personnel (HCP)

Authors and Disclosures

Thomas R. Talbot, MD, MPH;¹ Hilary Babcock, MD, MPH;² Deborah Cotton, MD, MPH;^3,4 Lisa L. Maragakis, MD, MPH;⁵ Gregory A. Poland, MD;⁶ Edward J. Septimus, MD;^7,8 Michael L. Tapper, MD;⁹ David J. Weber, MD, MPH,¹⁰ writing as the SHEA Task Force on Healthcare Personnel Influenza Vaccination

1. Departments of Medicine and Preventive Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; 2. Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri; 3. Department of Medicine, Boston University School of Medicine, Boston, Massachusetts; 4. Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts; 5. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; 6. Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota; 7. Hospital Corporation of America, Nashville, Tennessee; 8. Texas A&M Health Science Center, Bryan, Texas; 9. Lenox Hill Hospital and the New York University School of Medicine, New York, New York; 10. Departments of Medicine and Pediatrics, University of North Carolina, Chapel Hill, North Carolina.

Potential conflicts of interest
T.R.T. reports that he has served as an advisor to Joint Commission Resources; he has received honoraria from QuantiaMD; and his spouse has received research support from Wyeth, Vaxxinate, and Sanofi Pasteur. H.B. reports that she has received honoraria from Sanofi Pasteur. G.A.P. reports that he has served as an advisor or consultant to Merck, Avianax, Liquidia Technologies, Novartis Vaccines, PAXVAX, CSL Biotherapies, and Sanofi Pasteur. M.L.T. reports that he served as an advisor or consultant to Genentech and Pfizer and has received honoraria from Gilead Sciences. D.J.W. has served as an advisor or consultant to Merck and Pfizer and has received honoraria from Pfizer, Merck, and Sanofi Pasteur. L.L.M., D.C., and E.J.S. report no conflicts of interest relevant to this article. All authors submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest, and the conflicts that the editors consider relevant to this article are disclosed here.

Address correspondence to
Thomas R. Talbot, MD, MPH, A-2200 Medical Center North 1161 21st Avenue South, Vanderbilt University Medical Center, Nashville, TN 37232 (tom.talbot@vanderbilt.edu).